Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is better prepared than before COVID-19 in several key areas but remains insufficiently ready for another major pandemic or widespread health crisis, according to bipartisan commissions, GAO assessments, state-level reviews, and other expert analyses. Progress has been made in stockpiles, surveillance, medical countermeasures, and some coordination structures, yet persistent gaps in leadership, sustained funding, state/local capacities, workforce, supply chains, data systems, and public trust leave significant vulnerabilities. Biological threats (natural, accidental, or deliberate) are real and growing.[1]
Improvements Since COVID-19
The Biden-Harris Administration and subsequent efforts documented substantial enhancements:
These steps address some COVID-era failures (e.g., early PPE shortages, slow testing scale-up, fragmented data).
Persistent Gaps and Criticisms
Independent reviews highlight that progress is incomplete and fragile:
The 2024 National Preparedness Report and other assessments note pandemics as top stressing hazards alongside cyber and natural disasters, with resource strains from concurrent events.
Bottom Line and Path Forward
The US has stronger tools (stockpiles, platforms, surveillance, some structures) and institutional memory than in early 2020, enabling faster initial responses to threats like H5N1 or mpox. However, it is not fully prepared for a high-impact, prolonged, or novel crisis on the scale of (or worse than) COVID-19. Vulnerabilities in sustained investment, multi-level coordination, equity, trust, and resilience could again lead to high excess mortality, economic damage, and societal disruption. Expert consensus (bipartisan commissions, GAO, TFAH, academic analyses) calls for continuous “on all the time” biodefense: stronger White House leadership, stable multi-year funding, closing open recommendations, bolstering SLTT capacities and workforce, resilient domestic supply chains, better data/equity systems, and regular exercises/after-actions.
Preparedness is a spectrum and ongoing process, not a binary. Recent progress is real and valuable but incomplete and at risk of backsliding without sustained political will and resources. Ongoing threats (e.g., zoonoses like H5N1, antimicrobial resistance, potential engineered pathogens) underscore the urgency.
Citations (8)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Biological threats (natural, accidental, or deliberate) are real and growing.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Domestic manufacturing has been boosted via contracts and Defense Production Act authorities. The SNS has supported responses to H5N1, mpox, and others.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Improved modeling, forecasting (e.g., CDC’s Center for Forecasting and Outbreak Analytics), and lab partnerships (including “warm base” awards for rapid testing scale-up).”
- https://iris.who.int/bitstream/handle/10665/380155/9789240105409-eng.pdf?sequence=1sask
Backs: “WHO’s 2024 Joint External Evaluation (JEE) of US IHR core capacities noted strong performance in many technical areas (high scores in detection, response, and prevention indicators in available summaries) while recommending further improvements.”
- https://www.gao.gov/products/gao-24-107175
Backs: “High-risk areas include HHS leadership/coordination of public health emergencies.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “All states need improvement; concurrent disasters strain resources.”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “COVID supplemental funds have wound down; state public health budgets face pressure. PAHPA authorization-appropriations gaps continue.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “NEJM and other analyses warn of “déjà vu” risks if lessons are not fully heeded.”